Fair value (multi-method)
Four independent methods triangulate what EW is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$42.73
Method range
$16.24 – $96.83
median $66.99
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $42.73 | -50.29% |
| Exit multiple | $91.24 | +6.14% |
| Analyst target | $96.83 | +12.65% |
| Graham number | $16.24 | -81.11% |
- Forward DCF$42.73
- Exit multiple$91.24
- Analyst target$96.83
- Graham number$16.24
Stock price
$85.96
EPS (TTM)
$1.88
5Y EPS CAGR
7.1%
Fair value @ hist. growth
$42.73
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied EPS growth
16.3%
per year over your projection horizon
Margin of safety -101.2% vs hist-growth DCF
Historical 5Y CAGR
7.1%
Your model implies
16.3%
Next-year analyst consensus
60.2%
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.9% | 12.7% | 11.8% | 10.8% | 9.6% | 8.3% |
| 7.9% | 15.3% | 14.5% | 13.7% | 12.8% | 11.7% |
| 8.9% | 17.7% | 17.0% | 16.3% | 15.5% | 14.7% |
| 9.9% | 19.9% | 19.3% | 18.7% | 18.0% | 17.3% |
| 10.9% | 22.0% | 21.5% | 20.9% | 20.3% | 19.7% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.10
Low vs growth
Net cash
$2.2B
Total debt − cash
Beta
0.87
Vs market benchmark
Annual diluted EPS
Per-share earnings by fiscal year — last 5 years anchor the CAGR reference above.
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation